Column Capital Advisors, LLC Catalyst Pharmaceuticals, Inc. Transaction History
Column Capital Advisors, LLC
- $1.92 Billion
- Q3 2023
A detailed history of Column Capital Advisors, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Column Capital Advisors, LLC holds 300 shares of CPRX stock, worth $6,765. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300
Previous 300
-0.0%
Holding current value
$6,765
Previous $4,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CPRX
# of Institutions
330Shares Held
94.7MCall Options Held
19.1KPut Options Held
51.1K-
Black Rock Inc. New York, NY18.7MShares$422 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.04MShares$181 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY6.23MShares$140 Million2.3% of portfolio
-
State Street Corp Boston, MA5.69MShares$128 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.02MShares$68.1 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.32B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...